Johan Löf

President & CEO, Raysearch Laboratories

Search every verified Johan Löf interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Johan Löf, President and CEO of RaySearch Laboratories, stated that the company has set a clear target of achieving a 20 percent operating margin by 2026, and he expressed confidence in reaching that goal. He described RaySearch as a pure software company that develops treatment planning software for cancer care, noting that more than 50 percent of cancer patients receive radiation therapy and that the number of new cancer cases is expected to rise to 35 million by 2050. Löf highlighted that RayStation supports a wide range of different treatment machines, which he described as a strong competitive advantage. He said that clinics with mixed equipment can use RayStation as a single platform, allowing staff to work with one system and treat patients on various machines. He also noted that approximately 40 percent of the company's revenue is recurring, while the remainder comes from license sales, with many clinics still preferring to purchase perpetual licenses and support.